Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Biliary Tract Diseases

Free Subscription Articles published in Lancet Retrieve available abstracts of 4 articles: HTML format

Single Articles

September 2024
1. TANAKA A, Ma X, Takahashi A, Vierling JM, et al
   Primary biliary cholangitis.
   Lancet. 2024;404:1053-1066.
   PubMed     Abstract available
   
   
   April 2023
2. SLATER S, Cunningham D
   Pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer.
   Lancet. 2023 Apr 14:S0140-6736(23)00767-5. doi: 10.1016/S0140-6736(23)00767.
   PubMed    
   
   
   
3. KELLEY RK, Ueno M, Yoo C, Finn RS, et al
   Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
   Lancet. 2023 Apr 14:S0140-6736(23)00727-4. doi: 10.1016/S0140-6736(23)00727.
   PubMed     Abstract available
   
   
   March 2023
4. ZAROCOSTAS J
   Global health experts welcome Kasai dismissal.
   Lancet. 2023;401:890.
   PubMed    
   
   

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.